DRC & Research News

This page shares the latest news in T1D research and DRC’s community.

Get the most recent diabetes research news, delivered straight to your inbox

Pediatrician with Diabetic Child

Change in Gut Bacteria May Precede Type 1 Diabetes in Kids

Pediatrician with Diabetic ChildTHURSDAY, Feb. 5, 2015 (HealthDay News) — In some young children who develop type 1 diabetes, a change in normal stomach bacteria can precede the disease by a year, a small study has found.

The findings, published Feb. 5 in the journal Cell, Host & Microbe, are based on just 33 children at increased genetic risk of type 1 diabetes. And experts stressed that it’s too early to tell what it all could mean.

But one hope is that the results will lead to an early diagnostic test for type 1 diabetes, said researcher Aleksandar Kostic, a postdoctoral fellow at the Broad Institute of MIT and Harvard.

There is also the possibility of developing new therapies for type 1 that would target the “ecosystem” of the gut, he said.

But that would be a long way off, Kostic stressed. “These findings open up a promising new avenue for more research,” he said. “But that’s all we can say for now.”

Type 1 diabetes differs from the much more common type 2 diabetes, which is often linked to older age and obesity. In type 1, the immune system mistakenly kills off pancreatic cells that make the blood-sugar-regulating hormone insulin. To survive, people with type 1 have to take frequent injections of insulin, or use an insulin pump, for the rest of their lives.

As many as 3 million Americans have type 1 diabetes, according to the JDRF (formerly Juvenile Diabetes Research Foundation), a New York-based organization that funds research into the disease. Often, the disease arises in childhood, but there are adult-onset cases, too.

Scientists do not know exactly what causes the abnormal immune reaction. But people who carry certain gene variants related to immune system function have a higher-than-normal risk of developing type 1 diabetes.

The new study followed 33 babies from Finland and Estonia who carried some of those gene variants. Kostic and his colleagues analyzed stool samples from the children to chart changes in the trillions of bacteria, viruses and other microorganisms that dwell in the gut — what scientists call the “microbiome.”

By age 3 years, four children had developed type 1 diabetes. And those children showed a clear change in gut “bugs” about one year before the onset of the disease.

“What we saw were huge alterations,” Kostic said. “That included a drop in the overall diversity of the ‘community.'”

He likened the situation to a rain forest that is being cleared. The decline in its natural diversity opens the door for some “bad players” to take root.

In this case, children who went on to develop diabetes showed a decline in “good bugs” that produce beneficial fatty acids, and an increase in organisms linked to inflammation, Kostic explained.

But it’s not clear, he said, whether that shift in the gut helps cause the abnormal immune reaction behind type 1 diabetes or results from it. That’s a question for future research, Kostic said.

Another expert agreed. A big next step will be to understand the physiological “pathways” that the gut microorganisms affect, said Jessica Dunne, director of discovery research for JDRF, which funded the study.

“We’re still a long way off from a therapy,” Dunne said. But, she added, researchers are already interested in whether a “probiotic” therapy might help prevent or delay type 1 diabetes in children at increased risk. Probiotics are live bacteria like those found naturally in the human body.

Another question, Kostic said, is whether these findings in toddlers would be true of older children or adults who develop type 1 diabetes. He said it’s fairly uncommon for the disease to be diagnosed by age 3, and it’s possible there’s something “unique” about children who develop it that early.

Dunne agreed that the disease process could be different in other age groups.

If a change in gut bacteria is a sign of diabetes to come, that could offer a way to catch the disease process early, Kostic and Dunne said.

However, only a small minority of kids who carry susceptibility genes actually develop type 1 diabetes, Kostic noted. “So genetics doesn’t tell you much,” he said.

Dunne said researchers would like to develop some way to predict which kids seem to be “on the path” to type 1 diabetes. That will be needed if any therapies to prevent or delay the disease become available.


SOURCES: Aleksandar Kostic, Ph.D., postdoctoral fellow, Broad Institute of MIT and Harvard, Cambridge, Mass.; Jessica Dunne, Ph.D., director, discovery research, JDRF, New York City; Feb. 5, 2015, online, Cell, Host & Microbe



Learn More +


See our approved research projects and campaigns.

Role of the integrated stress response in type 1 diabetes pathogenesis
In individuals with type 1 diabetes (T1D), the insulin-producing beta cells are spontaneously destroyed by their own immune system. The trigger that provokes the immune system to destroy the beta cells is unknown. However, accumulating evidence suggest that signals are perhaps first sent out by the stressed beta cells that eventually attracts the immune cells. Stressed cells adapt different stress mitigation systems as an adaptive response. However, when these adaptive responses go awry, it results in cell death. One of the stress response mechanisms, namely the integrated stress response (ISR) is activated under a variety of stressful stimuli to promote cell survival. However, when ISR is chronically activated, it can be damaging to the cells and can lead to cell death. The role of the ISR in the context of T1D is unknown. Therefore, in this DRC funded study, we propose to study the ISR in the beta cells to determine its role in propagating T1D.
Wearable Skin Fluorescence Imaging Patch for the Detection of Blood Glucose Level on an Engineered Skin Platform
A Potential Second Cure for T1D by Re-Educating the Patient’s Immune System
L Ferreira
Validating the Hypothesis to Cure T1D by Eliminating the Rejection of Cells From Another Person by Farming Beta Cells From a Patient’s Own Stem Cells
Han Zhu
Taming a Particularly Lethal Category of Cells May Reduce/Eliminate the Onset of T1D
JRDwyer 2022 Lab 1
Can the Inhibition of One Specific Body Gene Prevent Type 1 Diabetes?
Is Cholesterol Exacerbating T1D by Reducing the Functionality and Regeneration Ability of Residual Beta Cells?
Regeneration Ability of Residual Beta Cells
A Call to Question… Is T1D Caused by Dysfunctionality of Two Pancreatic Cells (β and α)?
Xin Tong
Novel therapy initiative with potential path to preventing T1D by targeting TWO components of T1D development (autoimmune response and beta-cell survival)
flavia pecanha